Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balazs Acs

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 15, 2019
Quantitative assessment of PD-L1 as an analyte in immunohistochemistry diagnostic assays using a standardized cell line tissue microarraySandra Martinez-Morilla, John McGuire, Patricia Gaule, et al.
Journal of the National Cancer Institute|December 28, 2020
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working GroupTorsten O Nielsen, Samuel C Y Leung, David L Rimm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Deep Learning Based on Standard H&E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and DeathPrathamesh M Kulkarni, Eric J Robinson, Jaya Sarin Pradhan, et al.
Nature Communications|April 8, 2026
Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trialAlexios Matikas, Evangelos Tzoras, Michail Sarafidis, et al.
Scientific Reports|February 3, 2021
Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanomaMichael R Moore, Isabel D Friesner, Emanuelle M Rizk, et al.
Cancers|October 13, 2021
Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working GroupMieke R Van Bockstal, Maxine Cooks, Iris Nederlof, et al.
Histopathology|February 5, 2026
Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma: A report on behalf of the International Immuno-Oncology Biomarker Working GroupYlva A Weeda, Roberto Salgado, Filip van Herpe, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2022
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional studyBalazs Acs, Samuel C Y Leung, Kelley M Kidwell, et al.
JAMA Network Open|July 3, 2025
Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in MelanomaThazin N Aung, Matthew Liu, David Su, et al.
The Journal of Pathology|August 23, 2023
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerDavid B Page, Glenn Broeckx, Chowdhury Arif Jahangir, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 15, 2019
Quantitative assessment of PD-L1 as an analyte in immunohistochemistry diagnostic assays using a standardized cell line tissue microarraySandra Martinez-Morilla, John McGuire, Patricia Gaule, et al.
Journal of the National Cancer Institute|December 28, 2020
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working GroupTorsten O Nielsen, Samuel C Y Leung, David L Rimm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Deep Learning Based on Standard H&E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and DeathPrathamesh M Kulkarni, Eric J Robinson, Jaya Sarin Pradhan, et al.
Nature Communications|April 8, 2026
Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER + /HER2- breast cancer: a randomized phase II trialAlexios Matikas, Evangelos Tzoras, Michail Sarafidis, et al.
Scientific Reports|February 3, 2021
Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanomaMichael R Moore, Isabel D Friesner, Emanuelle M Rizk, et al.
Cancers|October 13, 2021
Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working GroupMieke R Van Bockstal, Maxine Cooks, Iris Nederlof, et al.
Histopathology|February 5, 2026
Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma: A report on behalf of the International Immuno-Oncology Biomarker Working GroupYlva A Weeda, Roberto Salgado, Filip van Herpe, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 21, 2022
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional studyBalazs Acs, Samuel C Y Leung, Kelley M Kidwell, et al.
JAMA Network Open|July 3, 2025
Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in MelanomaThazin N Aung, Matthew Liu, David Su, et al.
The Journal of Pathology|August 23, 2023
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerDavid B Page, Glenn Broeckx, Chowdhury Arif Jahangir, et al.
Pageof 6